SWP
AVXL icon

Stratos Wealth Partners’s Anavex Life Sciences AVXL Stock Holding History

Stratos Wealth Partners’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,600
Closed -$245K – 1551
2025
Q2 		$245K Buy
+26,600
New +$227K ﹤0.01% 1228
2025
Q1 		– Sell
-22,457
Closed -$241K – 1373
2024
Q4 		$241K Buy
+22,457
New +$173K ﹤0.01% 1264
2024
Q2 		– Sell
-10,802
Closed -$55K – 1377
2024
Q1 		$55K Buy
+10,802
New +$60.8K ﹤0.01% 1359
2021
Q2 		– Sell
-11,100
Closed -$166K – 1190
2021
Q1 		$166K Buy
+11,100
New +$121K ﹤0.01% 1062

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return